Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Sofinnova Capital X investment portfolio

Sofinnova Capital X has made numerous investments in companies such as Myricx Pharma, Purespring Therapeutics, and T-Therapeutics within the Healthcare & Life Sciences sector.

vc
Portfolio
3
Team
0

Portfolio (3)

CompanySectorSourceLast confirmed on
Myricx Pharma Limited
MYRICX PHARMA LIMITED, also known as Myricx Bio, is a UK biotech company focused on discovering and developing novel payloads for antibody-drug conjugates (ADCs). These payloads are N-myristoyltransferase (NMT) inhibitors designed to selectively target and kill cancer cells, with a primary focus in oncology.
Healthcare & Life SciencesConfirmed2025-07-02
Purespring Therapeutics LimitedHealthcare & Life SciencesConfirmed2026-03-31

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (4)

Sofinnova Capital X's positions across portfolio companies
2026
2025

Sign up free to see when this investor has bought or sold shares.

+2 more changes

Sign up